Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 16, 2025 08:00 ET | Source: SpyGlass Pharma, Inc.

SpyGlass Pharma Appoints Anand Sundaram as Head of Commercial

ALISO VIEJO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a late-stage biopharmaceutical company, today announced the appointment of Anand Sundaram as the company’s Vice President,...
August 19, 2025 08:00 ET | Source: SpyGlass Pharma, Inc.

SpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors

ALISO VIEJO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately held ophthalmic biotechnology company, today announced the appointment of Elizabeth (Liz) O’Farrell to its...
June 25, 2025 10:00 ET | Source: Gordon Schanzlin New Vision Institute

Gordon Schanzlin New Vision Institute Becomes First U.S. Clinic to Use Alcon’s Breakthrough Unity Phaco System

San Diego, CA, June 25, 2025 (GLOBE NEWSWIRE) -- Gordon Schanzlin New Vision Institute is proud to announce it is the first clinic in the United States to use both the Unity® Vision Centerpiece...
June 02, 2025 08:00 ET | Source: SpyGlass Pharma, Inc.

SpyGlass Pharma Raises $75 Million Series D Funding to Advance Its Long-term Drug Delivery Platform for Glaucoma Patients

Financing supports SpyGlass Pharma’s platform through the readout of two Phase III pivotal trials ALISO VIEJO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a privately held ophthalmic...
April 24, 2025 08:00 ET | Source: SpyGlass Pharma, Inc.

SpyGlass Pharma Presents 18-Month Data Demonstrating Compelling Visual Acuity Results with Their IOL-mounted Innovative Drug Delivery Platform

All patients achieved 20/30 or better best corrected distance visual acuity (BCDVA)Significant IOP reduction at 18 months was also demonstrated with 100% of patients off all topical IOP-lowering...
March 27, 2025 08:00 ET | Source: SpyGlass Pharma, Inc.

SpyGlass Pharma Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer

Dr. Pujara brings extensive industry experience to guide late-stage development of the SpyGlass Drug Delivery Platform ALISO VIEJO, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a...
February 19, 2025 09:00 ET | Source: The Eye Health Summit

Inaugural Eye Health Summit Empowers Public with Integrative Vision Care Insights from Leading Experts

The Eye Health Summit, a new global patient-centered event dedicated to integrative eye health, will take place May 1–7 as a free hybrid event.
April 30, 2024 09:00 ET | Source: Nacuity Pharmaceuticals, Inc.

Nacuity Pharmaceuticals Announces First Patients Implanted in Final Cohort of Phase 1/2 Clinical Trial Evaluating NPI-002 Intravitreal Implant for the Delay of Cataract Progression

Two patients have been implanted in the final cohort of the trial Final cohort is actively enrolling adult patients undergoing vitrectomy FORT WORTH, Texas, April 30, 2024 (GLOBE NEWSWIRE) --...
December 05, 2023 09:00 ET | Source: SpyGlass Pharma, Inc.

SpyGlass Pharma Strengthens Leadership to Further Advance its Intraocular Drug Delivery Platform

Margot Goodkin, M.D., Ph.D., appointed Chief Medical OfficerBilal Khan, MBA, CEO of New World Medical, appointed to the SpyGlass Board of Directors ALISO VIEJO, Calif., Dec. 05, 2023 (GLOBE...
October 31, 2023 07:00 ET | Source: SpyGlass Pharma, Inc.

SpyGlass Pharma Initiates Phase I/II Clinical Trial of its Intraocular Drug Delivery Platform

ALISO VIEJO, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately-held ophthalmic biotechnology company, announced today the initiation of a Phase I/II clinical trial...